Optimal adaptive two-stage designs for early phase II clinical trials | Center for Neurodegeneration and Translational Neuroscience (CNTN)

Shan G, Wilding GE, Hutson AD, Gerstenberger S

Stat Med

January 2016

← Back to Publications